Predicting long-term type 2 diabetes with support vector machine using oral glucose tolerance test by Abbas, Hasan T. et al.
RESEARCH ARTICLE
Predicting long-term type 2 diabetes with
support vector machine using oral glucose
tolerance test
Hasan T. AbbasID1¤*, Lejla Alic2, Madhav Erraguntla3, Jim X. JiID1, Muhammad Abdul-
Ghani4, Qammer H. Abbasi5, Marwa K. Qaraqe6
1 Department of Electrical & Computer Engineering, Texas A&M University at Qatar, Doha, Qatar, 2 Magnetic
Detection & Imaging Group, Faculty of Science & Technology, University of Twente, Enschede, The
Netherlands, 3 Department of Industrial & Systems Engineering, Texas A&M University, College Station,
Texas, United States of America, 4 UT Health, San Antonio, Texas, United States of America, 5 James Watt
School of Engineering, University of Glasgow, Glasgow, United Kingdom, 6 College of Science and
Engineering, Hamad Bin Khalifa University, Doha, Qatar
¤ Current Address: James Watt School of Engineering, University of Glasgow, Glasgow, United Kingdom
* hasan.abbas@qatar.tamu.edu, Hasan.Abbas@glasgow.ac.uk
Abstract
Diabetes is a large healthcare burden worldwide. There is substantial evidence that lifestyle
modifications and drug intervention can prevent diabetes, therefore, an early identification
of high risk individuals is important to design targeted prevention strategies. In this paper,
we present an automatic tool that uses machine learning techniques to predict the develop-
ment of type 2 diabetes mellitus (T2DM). Data generated from an oral glucose tolerance
test (OGTT) was used to develop a predictive model based on the support vector machine
(SVM). We trained and validated the models using the OGTT and demographic data of
1,492 healthy individuals collected during the San Antonio Heart Study. This study collected
plasma glucose and insulin concentrations before glucose intake and at three time-points
thereafter (30, 60 and 120 min). Furthermore, personal information such as age, ethnicity
and body-mass index was also a part of the data-set. Using 11 OGTT measurements, we
have deduced 61 features, which are then assigned a rank and the top ten features are
shortlisted using minimum redundancy maximum relevance feature selection algorithm. All
possible combinations of the 10 best ranked features were used to generate SVM based
prediction models. This research shows that an individual’s plasma glucose levels, and
the information derived therefrom have the strongest predictive performance for the future
development of T2DM. Significantly, insulin and demographic features do not provide addi-
tional performance improvement for diabetes prediction. The results of this work identify the
parsimonious clinical data needed to be collected for an efficient prediction of T2DM. Our
approach shows an average accuracy of 96.80% and a sensitivity of 80.09% obtained on a
holdout set.
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Introduction
The global incidence of diabetes was estimated at 422 million in the year 2014 and its preva-
lence among the adult population increased from 4.7% in 1980 to 8.5% in 2014 [1]. In 2015
alone, about 1.6 million deaths worldwide were attributed to diabetes. In addition to the high
mortality rate, an individual with diabetes is at a greater risk of developing cardiovascular dis-
ease (CVD), visual impairment and limb amputations, as compared to a non-diabetic individ-
ual. Due to the substantial socio-economic burdens that are associated with diabetes, its early
detection, prevention, and management has become a worldwide top-level health concern.
There is experimental evidence that the development of diabetes can be delayed or even pre-
vented provided an individual undertakes a lifestyle change that includes diet management,
adopting exercise, and adhering to a pharmacological treatment [2]. The early identification of
high risk individuals of diabetes is therefore, essential for targeted prevention strategies [3].
Even though the number of clinical studies aimed at diagnosing diabetes has been growing
recently, studies predicting the risk of developing diabetes are limited. This subject has lately
received an increased amount of research interest [4]. However, the clinical significance of
such predictions largely depend on the type and quality of data collected. There are studies
that assign a probability to the future risk of diabetes using socio-demographic characteristics
such as age, ethnicity, body-mass index (BMI) and genealogical information collected through
population [5, 6]. Due to the unreliable data collection, such techniques can be misleading.
The collection of blood samples, on the other hand, provides more reliable data and is a first
step towards the disease prognosis with a deeper clinical insight [7]. The oral glucose tolerance
test (OGTT) is commonly used to screen diabetes [8] and to provide a critical understanding
of its future evolution [9]. In an OGTT, the plasma glucose and insulin levels are measured at
regular intervals in a 2-hr period after orally administering a standard dose of glucose [9]. The
glucose tolerance and insulin resistance are two of the most significant parameters deduced
from the OGTT that are widely regarded as the major factors in the development of type 2 dia-
betes mellitus (T2DM).
A precursory stage of diabetes, commonly referred to as prediabetes, exists before overt
T2DM, and is described by impaired fasting glucose (IFG), along with impaired glucose toler-
ance (IGT). According to the World Health Organization (WHO) diagnostic criteria, the IFG
is defined as fasting plasma glucose level of 100 mg/dL to 125 mg/dL. The IGT which describes
an abnormally raised glucose level is defined as the 2-hour plasma glucose level in the range of
140 mg/dL to 199 mg/dL, measured during the OGTT [10]. Although prediabetes is consid-
ered as an intermediate stage in the natural progression of T2DM [11], it has been reported
that only 50% of the subjects diagnosed with IGT developed diabetes within 10 years [12, 13].
Moreover, long-term population studies have also shown that around 50% of the diabetic
patients did not exhibit IGT at any time prior to the diagnosis [14]. This suggests that the fast-
ing and 2-hour plasma glucose levels used in and of themselves cannot accurately predict the
future development of T2DM.
The availability of big data in the healthcare sector has made machine learning (ML) a via-
ble instrument for disease prediction [15–18]. In contrast to traditional diagnostic techniques
employing population based statistics, ML methods develop models that are trained using
large amounts of data. In a pilot study, Maeta et al developed a ML algorithm to predict the
risk of developing glucose metabolism disorder using the OGTT data [19]. Barakat et al used
socio-demographic information, and point-of-care testing from blood and urine to develop
diagnostic models of diabetes [20]. This approach uses support vector machine (SVM) along
with a rule-based explanation to provide a comprehensibility of the results to the clinicians.
The plasma glucose levels at baseline and 2-hr were among the features used. Han et al
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employed an ensemble SVM and random forest learning approaches to develop a decision
making algorithm for the diagnosis of diabetes [21]. However, investigations that are designed
to identify individuals at high risk of developing T2DM in the long-term future are limited.
The San Antonio diabetes prediction model (SADPM) [22] uses a logistic regression supported
by physiological parameters such as systolic blood pressure and cholesterol level. The underly-
ing causes of T2DM in the form insulin resistance and insulin secretion were studied to
develop a prediction model in [14]. In another study, multivariate logistic models using the
plasma glucose values measured in the OGTT were used to predict the future risk of develop-
ing T2DM [23, 24]. The predictive power of different bio-markers such as the fasting plasma
glucose level, BMI and haemoglobin A1C (HbA1c) for T2DM onset was assessed in [25]. This
study focused on individuals with metabolic syndrome, a complex and serious health condi-
tion that greatly increases the risk of CVD and diabetes.
The standard ML algorithms are designed to yield optimal performance in terms of accu-
racy over the full data-set. However, medical applications such as diagnosis and prediction of
a disease require a biased decision-making mechanism that favours one of the classes. This
approach inherently maximises the performance of the class that is more relevant in clinic
terms. Therefore, the objective in such applications is to design a classifier that improves the
accuracy of the class that is clinically more relevant. Additionally, often the amount of data is
highly skewed with the clinically relevant class in an out-sized minority. There are various
roundabout ways to obtain accurate classifier performance in this scenario that include the
method of sampling [26] in which the class distribution is artificially balanced by either under
sampling the majority class, over-sampling the minority class or both. Furthermore, feature
weighting schemes assign distinct costs to training examples [27] in order to introduce a cer-
tain bias. Other techniques introduce evaluation metric such as the geometric mean (g-mean)
[28], that concurrently optimises the positive class accuracy (sensitivity) and the negative class
accuracy (specificity) [29].
We hypothesised that the features extracted from the OGTT will be able to predict the
future onset of T2DM. In this paper, we therefore propose a screening tool that identifies the
most relevant features extracted from the OGTT data that strongly correlate with the future
development of T2DM. We then use SVM to develop a prediction model by utilising these rel-
evant features estimated from the longitudinal cohort study, the San Antonio Heart Study
(SAHS) [30, 31].
Materials and methods
San Antonio Heart Study
The SAHS is a population-based epidemiological study that was conducted to assess the risk
factors of diabetes and cardiovascular diseases in healthy population [30, 31]. In total, 5,158
men and non-pregnant women of Mexican American (MA) and non-Hispanic White (NHW)
residents of San Antonio, Texas participated in the study in two cohorts. The age of individuals
at the time of recruitment was between 25 and 64 years. As a part of the data collection, plasma
glucose and serum insulin concentrations were collected during the OGTT at the baseline and
after an average follow-up of 7.5 years. The BMI was also recorded for each individual at the
baseline. In this study, we analysed only the data generated from the second cohort of the
SAHS which comprised of 1,492 subjects from the second cohort of the SAHS.
T2DM was diagnosed at the follow-up using the WHO criteria, i.e. fasting glucose
level> 126 mg/dL or 2-hr glucose level�200 mg/dL [10]. Furthermore, all individuals taking
anti-diabetic medications were also classified as having T2DM. Individuals that reported by
themselves any cardiovascular event such as a heart attack, stroke or angina, were labelled as
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having CVD at the follow-up. All other participants without T2DM or self-reported CVD were
labelled as healthy for the case of this study. During the course of this longitudinal study, a
total of 171 individuals developed T2DM with 10 individuals also reporting at least one cardio-
vascular event. The incidence rate of T2DM in the second cohort of the SAHS population was
10.79%. Table 1 shows the population distribution in terms of the four classes. The distribution
in terms of the ethnicity shows the T2DM prevalence among the MA individuals more than
double, as compared to the NHW population.
The data used in this study consists of plasma glucose and serum insulin concentrations
sampled at the baseline, and at 30, 60 and 120 min thereafter. The individuals are labelled at
the SAHS follow-up using the current standard of care [30]. Fig 1 shows the distributions of
the data used in this study.
Machine learning framework
In this paper, we implemented SVM to construct the models for the prediction of future
T2DM. The SVM develops models from a given training data-set such that it generalises well
to a new data-set and minimises the empirical risk associated with misclassification of samples
in the training set [32, 33]. A model constructed by the SVM minimises the overlap between
classes in the training set by optimising the separating hyper-plane. For problems that may not
be amenable to linear separation between the two classes, the SVM technique is very attractive
due to the fact that the input feature space can be transformed to a higher dimension space,
and a linear boundary can then be determined. This approach generally provides a better
training performance, but potentially increases computational complexity excessively with the
Table 1. The classification of the 1,492 subjects used in this study based on the ethnicity.
Healthy T2DM CVD T2DM+CVD
Total 1,277 161 44 10
85.56% 10.79% 2.95% 0.67%
MA 836 131 24 7
83.77% 13.13% 2.40% 0.70%
NHW 441 30 20 3
89.27% 6.07% 4.05% 0.61%
https://doi.org/10.1371/journal.pone.0219636.t001
Fig 1. Box plots of glucose and insulin levels for healthy and diabetic subjects measured at the baseline OGTT. A:
Plasma glucose. B: Serum insulin.
https://doi.org/10.1371/journal.pone.0219636.g001
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increase of the dimensionality of the input feature space [34]. The introduction of a kernel alle-
viates the need to determine the transformation by calculating the inner product between the
coordinates of the input feature space instead. In this paper, we used the Gaussian radial basis
function (RBF), as the kernel. The performance of the SVM can be optimised by tuning the
free parameter of the kernel σ and specifying a cost that controls the rigidity of the class mar-
gin. This process is normally carried out through a grid search.
Feature extraction
We extracted all the features from the SAHS data acquired at the baseline. The data-set consists
of plasma glucose and insulin concentrations recorded before glucose intake and at three
time-points thereafter (30, 60, and 120 min). The labels (healthy and diabetes) were generated
at the 7.5 years follow-up using the current standard of care diagnostics [30]. From the glucose
and insulin concentrations, we computed the slope and area under the curve between all the
possible combinations of a pair of measurements. In addition, we also calculated three empiri-
cal markers that describe the relationship between the glucose intake and insulin response.
The first is the insulinogenic index (IGI) [35], which is a direct measure of the insulin response
to glucose. It is calculated as the ratio of the slope of the insulin curve to the slope of the glucose
curve between any two time intervals in the OGTT. The second marker, Matsuda index (M)
evaluates the insulin sensitivity from the OGTT using a product of the weighted averages of
the glucose and insulin concentrations [36],
M ¼
10; 000
8
ffiffiffiffiffiffiffiffiffiffiffiffi
G0 � I0
p ½G0 þ 2G30 þ 2G60 þ 2G90 þ G120�
  1=2
�½I0 þ 2I30 þ 2I60 þ 2I90 þ I120�
  1=2
ð1Þ
where the subscripts depict the time point of the OGTT. In case when the value at 90 min is
not available, the average of 60 and 120 min is used instead [36]. The third marker, homeo-
static model assessment—insulin resistance (HOMA-IR) [37] evaluates the beta-cell function.
It is defined as the product of fasting plasma glucose concentration and fasting blood insulin
concentration divided by 22.5. These markers have been used to estimate abnormalities in the
insulin sensitivity. A total of 61 features (illustrated in Fig 2) are used in this study. The prefix
AuC denotes the area under the curve and the slope is denoted by the symbol Δ. The term Thalf
represents the linearly interpolated value between any two intervals.
Feature selection
Before constructing the SVM model to predict a future diabetes occurrence, we search for the
most effective subset of features in terms of relevance to the classifier output, i.e. incidence of
T2DM at the follow-up. As a first step, we selected the ten most relevant features from the 61
available features using the minimum redundancy maximum relevance (mRMR) algorithm
[38], which selects the most relevant features with minimum correlation among them. The
minimum redundancy maximum relevance (mRMR) algorithm determines the relevance
between a feature (x as continuous random variable) and the class label (y as discrete random
variable) in terms of the mutual information I defined as [39],
Iðx; yÞ ¼  
Z
pi ln pi dx  
X
j
pj ln pj þ
X
j
Z
pij ln pij dx; ð2Þ
where pi, and pj are the probabilities of the random variables x and y taking a particular value
xi and yj 2 (−1, 1)8j respectively. The term pij denotes the joint probability P{x = xi, y = yj}. The
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three terms in Eq (2) represent the continuous, discrete and joint entropies of the random vari-
ables in the respective order. The features that are most relevant to the class label are the ones
that maximize I . A heuristic approach is to keep only one a single feature from a correlated set
of features that provides similar relevance information, and discard the remaining features. In
order to ensure this, the mRMR algorithm minimizes the mutual correlation among the fea-
tures expressed in terms of redundancyR,
RðXÞ ¼
X
xi ;xj2X
Iðxi; xjÞ: ð3Þ
where I follows its definition in Eq (2). This procedure yielding maximum I with respect to
the diabetic class, along with minimalR, shortlists a set of ten features that are potentially
strong predictors of the future development of T2DM.
Classification
We developed a supervised learning scheme using the baseline SAHS data-set and the labels
(healthy, T2DM) obtained at the follow-up after an average of 7.5 years. In each experiment,
we used a kernel-based binary SVM method to train, test and validate the performance of the
diabetes prediction models. We excluded the 44 CVD entries as the only way of defining this
class was based upon self-reporting and not on quantitative assessment. Furthermore, we also
removed all entries with any information missing. That resulted in a total of 1,492 instances
that were used in this study, out of which 171 were from the minority class and 1,321 were
majority instances. As shown in Table 1, the SAHS data-set is intrinsically unbalanced with the
class distribution skewed toward the majority class with a ratio of 7.5:1. We considered the
minority class of diabetic subjects as the positive class with a label of 1, whereas the majority
class consisting of healthy persons was termed as the negative class marked by a ‘-1’ label. To
standardise the feature range prior to training, the feature space was scaled to unit variance
around the respective mean for each feature respectively. To ensure that a model was unbiased,
robust, and generalised well to the new data, we performed 10-fold cross-validation (CV). We
Fig 2. Illustration of all 61 features extracted from the SAHS data-set.
https://doi.org/10.1371/journal.pone.0219636.g002
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refrained from balancing the data-set so that the majority and minority class prevalence
becomes the same, as we believe this measure artificially boosts the classification performance.
For each CV, we first randomly selected a hold-out set consisting of 11 minority and 83
majority instances. We evaluated each model 100 times, in which the data was randomly parti-
tioned on each occasion. We compared the performances of linear and non-linear SVM for
all 1,023 possible combinations of the 10 most relevant features by considering all 1 to 10
combinations of features. The optimal hyper-plane parameters of the kernel were determined
through a grid search. To select the best feature set, we have used the geometric mean of sensi-
tivity and specificity [28]. All experiments were performed by an in-house developed software
using Matlab1(v9.2.0 MathWorks Inc., Natick, Massachusetts, USA).
Results and discussion
The mRMR algorithm produces a sequential list of ten ranked features, shown in Table 2.
Besides ethnicity (ranked fourth), all other features are notably derived from OGTT measure-
ments. The list contains six features derived from plasma glucose concentrations, while only
three features are deduced from insulin concentrations.
In all the classification experiments, we aimed to maximise the ability to correctly predict
the diabetic class without compromising the classifier accuracy. The bar plots in Fig 3 show the
g-mean of the sensitivity and specificity obtained from the linear and RBF kernels. For each
number of features used, we selected the combination that generated the maximum g-mean.
All the results presented here are averaged over 100 iterations of the respective classifiers.
The g-mean obtained from the linear SVM ranges from 0.8711 to 0.8742. As observed from
Table 2. List of ten most relevant features ranked by the mRMR algorithm.
Rank Feature
1 AuC-G0-120
2 ΔG120-0
3 ΔG120-60
4 Ethnicity
5 ΔI120-0
6 ΔG60-0
7 ΔG30-0
8 ΔG60-30
9 ΔI120-60
10 ΔI60-0
https://doi.org/10.1371/journal.pone.0219636.t002
Fig 3. The g-mean of sensitivity and specificity for A: linear, and B: RBF kernels. The maximum performance
feature combination is depicted by a different colour scheme.
https://doi.org/10.1371/journal.pone.0219636.g003
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Fig 3(a), the addition of more features does not result in a substantial performance improve-
ment. However, the maximum g-mean of the sensitivity and specificity is obtained when all 10
features are used. For the non-linear SVM with RBF kernel, the g-mean ranges from 0.8638 to
0.8903. The combination of the features namely, AuC-Glu0-120, ΔG120-0, ΔG120-60 and ΔG30-0
yields the maximum performance. Notably, all four features are derived from the plasma glu-
cose concentrations. We note that the glucose derived features are ranked the highest during
feature selection. Moreover, a combination of glucose only features generate the best SVM
models when less than four features are used.
The accuracy and sensitivity of the same feature combinations are separately shown in Fig
4. The best model obtained using a combination of four glucose derived features and RBF ker-
nel has an accuracy of 96.80%, and sensitivity of 80.09%.
Table 3 presents a comparison of the generated SVM models to the results obtained in
other studies using the SAHS data-set. We compared our results with the SADPM [22], in
which a person’s age, gender, ethnicity, fasting glucose level, family history, blood pressure,
and cholesterol level were used to construct a logistic regression. It is notable that the SADPM
has the highest sensitivity (88.80%) however, the increased prediction performance comes
along with a very low accuracy of 56.33%. In [23], a two-step approach was introduced that
first used the SADPM risk score and then augmented it with the 1-hour plasma glucose con-
centration measured in the OGTT. This strategy resulted in an improved accuracy but the sen-
sitivity dropped to 77.70%.
In the SAHS data-set, the prevalence of IFG and IGT was 8.91% (133 instances) and 22.52%
(336 instances) respectively. Out of the 399 subjects diagnosed with prediabetes showing IFG
or IGT at the baseline, only 120 (30.08%) actually developed diabetes between the baseline and
the follow-up. Furthermore, 120 (25.67%) subjects diagnosed with diabetes at the follow-up
did not show any symptoms of either IGT or IFG at the baseline.
Fig 4. The classifier performance in terms of accuracy and sensitivity for the best feature combinations. A: Linear
kernel. B: RBF kernel.
https://doi.org/10.1371/journal.pone.0219636.g004
Table 3. Comparison of validation performance of the best SVM classifiers with previous studies.
Accuracy ± SD Sensitivity ± SD Specificity ± SD g-mean ± SD
Linear SVM (10 features) 95.55% ± 0.24% 78.09% ± 0.33% 97.87% ± 0.30% 0.8742% ± 0.2100
SVM-RBF (4 features) 96.80% ± 0.41% 80.09% ± 1.42% 99.02% ± 0.33% 0.8903 ± 1.5600
SADPM [22] 56.329% 88.80% 52.00% 0.6795
Two-step Approach [23] 77.43% 77.70% 77.40% 0.7755
https://doi.org/10.1371/journal.pone.0219636.t003
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Our investigation shows that features derived from insulin have less predictive value for
T2DM as compared to glucose based features. Indices such as Matsuda and HOMA-IR that
are commonly used to assess the insulin function, also did not yield high correlation with the
future development of T2DM.
Conclusion
In this paper, we developed a non-linear SVM based prediction model that accurately identi-
fies the persons at a higher risk of developing T2DM in future. To develop the model, we first
assessed the predictive power of features that were derived from the OGTT data and were
augmented by personal information such as age, ethnicity, and BMI. Using a feature selection
algorithm, we demonstrated that the features deduced from the plasma glucose concentrations
provide the optimal feature subset and have the strongest predictive power for the future devel-
opment of T2DM. Moreover, the performance of the presented prediction model is signifi-
cantly better in terms of combined accuracy and sensitivity combined, compared to other
T2DM prediction models. In order to address the unbalanced nature of the SAHS data-set, we
chose the g-mean of sensitivity and specificity as the performance evaluation criteria. Our pre-
diction model outperforms other similar models by more than 12% in terms of the g-mean of
sensitivity and specificity. The mean accuracy, specificity and sensitivity achieved after 100
iterations were 96.80%, 99.02%, and 80.09%.
The principal contribution of this study includes a T2DM prediction model based on the
features derived only from the plasma glucose concentrations measured during an OGTT.
The findings of this paper provide a complementary and cost-effective tool for the clinicians to
screen individuals that are at an increased risk of developing T2DM in the future.
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